Generation of CD4+ and CD8+ T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes

被引:56
作者
Berlyn, KA
Schultes, B
Leveugle, B
Noujaim, AA
Alexander, RB
Mann, DL [1 ]
机构
[1] Univ Maryland, Sch Med, Div Immunogenet, Dept Pathol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Urol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA
[4] Alta Rex Corp, Waltham, MA 02451 USA
[5] Univ Alberta, Noujaim Inst Pharmaceut Oncol, Edmonton, AB T6G 2N8, Canada
关键词
dendritic cells; antigen processing; tumor immunity; antigens; peptides; epitopes; Fc receptors;
D O I
10.1006/clim.2001.5115
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DC) acquire antigens. through a number of cell surface structures including receptors. for the Fe portion of immunoglobulins and mannose. Little is known about the effects of antigen uptake via these receptors on antigen processing and presentation. We compared the capacity of DC to generate CD4(+) and CD8(+) T cell responses after exposure to prostate-specific antigen (PSA) alone, PSA targeted to the mannose receptor (mannosylated PSA (PSA-m)), or PSA targeted to Fe receptors by combining PSA with an anti-PSA antibody (AR47.47). Autologous CD3(+) T cells were added to monocyte-derived immature DC that had been cultured with GM-CS/IL-4 for 4 days, exposed to antigen, and matured with CD40L or TNF alpha/ IFN-alpha. After several rounds of stimulation, T cell responses were assessed by intracellular IFN-gamma production using. How cytometry. Both CD4(+) and CD8(+) T cell responses were observed after stimulation with DC exposed to the PSA/anti-PSA complexes, whereas CD4(+) predominated over CD8(+) T cell responses after stimulation with PSA-armed DC or PSA-m. These CDS' T cells responded when rechallenged with DC pulsed with BLA allele-restricted PSA peptides. These results indicate that PSA and PSA-in are processed primarily through pathways that favor HLA Class II presentation, while the PSA/anti-PSA immune complexes are processed through both Class I and Class II pathways in monocyte-derived DC. These findings have potential applications in designing more effective cancer vaccines for prostate cancer. (C) 2001 Elsevier Science.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 35 条
  • [1] Specific T cell recognition of peptides derived from prostate-specific antigen in patients with prostate cancer
    Alexander, RB
    Brady, F
    Leffell, MS
    Tsai, V
    Celis, E
    [J]. UROLOGY, 1998, 51 (01) : 150 - 157
  • [2] Autoimmune prostatitis: Evidence of T cell reactivity with normal prostatic proteins
    Alexander, RB
    Brady, F
    Ponniah, S
    [J]. UROLOGY, 1997, 50 (06) : 893 - 899
  • [3] Baiu DC, 1999, J IMMUNOL, V162, P3125
  • [4] Immunobiology of dendritic cells
    Banchereau, J
    Briere, F
    Caux, C
    Davoust, J
    Lebecque, S
    Liu, YT
    Pulendran, B
    Palucka, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +
  • [5] Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy
    Berlyn, KA
    Ponniah, S
    Stass, SA
    Malone, JG
    Hamlin-Green, G
    Lim, JK
    Cottler-Fox, M
    Tricot, G
    Alexander, RB
    Mann, DL
    Malone, RW
    [J]. JOURNAL OF BIOTECHNOLOGY, 1999, 73 (2-3) : 155 - 179
  • [6] CANCER STATISTICS, 1994
    BORING, CC
    SQUIRES, TS
    TONG, T
    MONTGOMERY, S
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (01) : 7 - 26
  • [7] Brawer MK, 2000, SEMIN SURG ONCOL, V18, P3, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<3::AID-SSU2>3.3.CO
  • [8] 2-9
  • [9] Coccia MA, 1998, J IMMUNOL, V161, P5772
  • [10] Corman JM, 1998, CLIN EXP IMMUNOL, V114, P166